Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
Sales | 3,673 | 2,515 | 2,325 | 1,083 | 1,581 |
Gross Profit | 3,673 | 2,515 | 2,325 | 1,083 | 1,581 |
Operating Expenses | 16,486 | 9,009 | 8,125 | 8,538 | 7,904 |
Operating Income | -12,813 | -6,494 | -5,800 | -7,455 | -6,323 |
Interest Expense | 40 | 38 | 50 | 78 | 96 |
Other Income | 547 | 494 | 261 | 198 | 204 |
Pre-tax Income | -12,306 | -6,038 | -5,589 | -7,335 | -6,215 |
Net Income Continuous | -12,306 | -6,038 | -5,589 | -7,335 | -6,215 |
Net Income | $-12,306 | $-6,038 | $-5,589 | $-7,335 | $-6,215 |
EPS Basic Total Ops | -0.53 | -0.26 | -0.31 | -0.30 | -0.37 |
EPS Basic Continuous Ops | -0.53 | -0.26 | -0.31 | 3.94 | -0.37 |
EPS Diluted Total Ops | -0.53 | -0.26 | -0.31 | -0.30 | -0.37 |
EPS Diluted Continuous Ops | -0.53 | -0.26 | -0.31 | 3.94 | -0.37 |
EBITDA(a) | $-12,593 | $-6,201 | $-5,494 | $-7,098 | $-6,017 |